DURHAM, N.C., DECEMBER 12, 2017 — When conducting clinical research on heart valve replacement and repair devices, fully engaging the entire trial team is vital to achieving effective operational oversight. Premier Research will examine why — and offer practical advice to medical device makers — at a live webinar on Tuesday, December 12 (11 a.m. EST / 4 p.m. GMT / 5 p.m. CST).
The stakes are high: the transcatheter aortic valve replacement market is expected to be nearly $4 billion by 2020, and demand for transcatheter mitral valve replacement devices is forecast to reach four times the size of today’s market for transcatheter aortic valve replacement.
Heart Valve Replacement: A Full-Team Approach for Operational Success will look at factors essential to success, such as:
- The valve study life cycle — planning milestones and other key decision points.
- The research team’s experience — globally, by region, and by country.
- Regional regulatory requirements—accounting for differences between FDA and EMA rules.
Register now for an informative hour.
About Premier Research
Premier Research is a leading clinical development service provider that helps highly innovative biotech, specialty pharma, and medical device companies transform breakthrough ideas into reality. The company has a wealth of experience in the execution of global, regional and local clinical development programs with a special focus on addressing unmet needs in areas such as analgesia, dermatology, medical device, neuroscience, oncology, pediatrics, and rare disease. Premier Research operates in 84 countries and employs 1,100 professionals, including a strong international network of clinical monitors and project managers, regulatory, data management, statistical, scientific, and medical experts. They are focused on smart study design for advanced medicines that allow life-changing treatments.